Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$177,131,838
New position
Shares Held
1,402,025
first reported quarter
Ownership
0.113%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#93
of 2,266 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 71%
Shared 0%
None 29%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Nykredit A/S holds $1,485,144,597 across 11 Drug Manufacturers - General names. GILD ranks #4 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
391,238 | $469,262,633 | |
| 2 | JNJ |
Johnson & Johnson
|
1,098,456 | $278,974,870 | |
| 3 | PFE |
Pfizer Inc
|
8,545,428 | $205,773,906 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
1,402,025 | $177,131,838 | |
| 5 | ABBV |
AbbVie Inc.
|
640,558 | $161,190,015 | |
| 6 | MRK |
Merck & Co., Inc.
|
778,827 | $100,079,269 | |
| 7 | AMGN |
Amgen Inc
|
149,626 | $54,182,567 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
506,199 | $29,167,186 |
All Filings in GILD
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $177,131,838 | 1,402,025 | Shares | Defined | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||